66 related articles for article (PubMed ID: 21235903)
1. Molecular and structural advances in tissue factor-dependent coagulation.
Kirchhofer D; Banner DW
Trends Cardiovasc Med; 1997 Nov; 7(8):316-24. PubMed ID: 21235903
[TBL] [Abstract][Full Text] [Related]
2. The factor VIIa/tissue factor complex.
Banner DW
Thromb Haemost; 1997 Jul; 78(1):512-5. PubMed ID: 9198205
[TBL] [Abstract][Full Text] [Related]
3. [The role of tissue factor and its inhibitor in hemostasis].
Naumnik B; Małyszko J; Myśliwiec M
Przegl Lek; 1998; 55(2):68-73. PubMed ID: 9695646
[TBL] [Abstract][Full Text] [Related]
4. Probing the S2 site of factor VIIa to generate potent and selective inhibitors: the structure of BCX-3607 in complex with tissue factor-factor VIIa.
Krishnan R; Kotian PL; Chand P; Bantia S; Rowland S; Babu YS
Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):689-97. PubMed ID: 17505107
[TBL] [Abstract][Full Text] [Related]
5. The lipoprotein-associated coagulation inhibitor.
Broze GJ; Girard TJ; Novotny WF
Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
[TBL] [Abstract][Full Text] [Related]
6. The structural basis of function of the TF. VIIa complex in the cellular initiation of coagulation.
Edgington TS; Dickinson CD; Ruf W
Thromb Haemost; 1997 Jul; 78(1):401-5. PubMed ID: 9198187
[TBL] [Abstract][Full Text] [Related]
7. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
Zhang E; St Charles R; Tulinsky A
J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.
Edgington TS; Mackman N; Fan ST; Ruf W
Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S15-27. PubMed ID: 1364116
[TBL] [Abstract][Full Text] [Related]
9. [Interaction of blood and the vascular wall: hemostatic aspects].
Gerlach E; Becker BF
Z Kardiol; 1993; 82 Suppl 5():13-21. PubMed ID: 8154153
[TBL] [Abstract][Full Text] [Related]
10. Molecular interaction between factor VII and tissue factor.
Higashi S; Iwanaga S
Int J Hematol; 1998 Apr; 67(3):229-41. PubMed ID: 9650444
[TBL] [Abstract][Full Text] [Related]
11. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
12. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor.
Banner DW; D'Arcy A; Chène C; Winkler FK; Guha A; Konigsberg WH; Nemerson Y; Kirchhofer D
Nature; 1996 Mar; 380(6569):41-6. PubMed ID: 8598903
[TBL] [Abstract][Full Text] [Related]
13. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C.
Safa O; Morrissey JH; Esmon CT; Esmon NL
Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263
[TBL] [Abstract][Full Text] [Related]
14. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
Parlow JJ; Case BL; Dice TA; Fenton RL; Hayes MJ; Jones DE; Neumann WL; Wood RS; Lachance RM; Girard TJ; Nicholson NS; Clare M; Stegeman RA; Stevens AM; Stallings WC; Kurumbail RG; South MS
J Med Chem; 2003 Sep; 46(19):4050-62. PubMed ID: 12954058
[TBL] [Abstract][Full Text] [Related]
15. Epitope location on tissue factor determines the anticoagulant potency of monoclonal anti-tissue factor antibodies.
Kirchhofer D; Moran P; Chiang N; Kim J; Riederer MA; Eigenbrot C; Kelley RF
Thromb Haemost; 2000 Dec; 84(6):1072-81. PubMed ID: 11154116
[TBL] [Abstract][Full Text] [Related]
16. An anti-tissue factor monoclonal antibody which inhibits TF.VIIa complex is a potent anticoagulant in plasma.
Ruf W; Edgington TS
Thromb Haemost; 1991 Nov; 66(5):529-33. PubMed ID: 1803616
[TBL] [Abstract][Full Text] [Related]
17. Design, parallel synthesis, and crystal structures of biphenyl antithrombotics as selective inhibitors of tissue factor FVIIa complex. Part 1: Exploration of S2 pocket pharmacophores.
Kotian PL; Krishnan R; Rowland S; El-Kattan Y; Saini SK; Upshaw R; Bantia S; Arnold S; Babu YS; Chand P
Bioorg Med Chem; 2009 Jun; 17(11):3934-58. PubMed ID: 19409795
[TBL] [Abstract][Full Text] [Related]
18. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
Almus FE; Rao LV; Rapaport SI
Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
[TBL] [Abstract][Full Text] [Related]
19. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
Ruf W; Shobe J; Rao SM; Dickinson CD; Olson A; Edgington TS
Biochemistry; 1999 Feb; 38(7):1957-66. PubMed ID: 10026279
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of Factor VIIa/tissue factor.
Shirk RA; Vlasuk GP
Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1895-900. PubMed ID: 17600222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]